TIDAL Launches Live
4.4.2023 15:00:00 CEST | Business Wire | Press Release
Today, global music platform TIDAL launched Live, a new in-app feature that makes it easy for HiFi and HiFi Plus TIDAL subscribers to share music in the moment without physically being together. Live makes it easy for groups of any size to come together for a special event, an album release, a road trip, or for a get ready with me moment.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230404005659/en/
Screenshot of the TIDAL Live user experience (Graphic: Business Wire)
Formerly beta tested as “DJ” through an early access program, Live is a new way for fans to spontaneously share music. The new feature makes it effortless for fans to also find and follow music tastemakers. When starting a Live session, TIDAL subscribers can choose the session name to set the tone for what they’re playing and share a link for others to join. Shareable links to Live sessions let anyone join - from text messages and social media, to emails.
To introduce Live, music fans can look out for Live sessions from Diplo, Aluna, and Alesso and many more! From 8am ET today, other Live sessions will be happening across US, UK, Germany, Poland, and Brazil for fans to join. Whether you’re traveling to meet friends, working out or cooking dinner there may be a Live session for you.
Starting today, subscribers can choose from specially curated sessions by TIDAL's genre experts throughout the week in the app. Live sessions will mark cultural moments, introduce rising artists to watch, and everyday activities where music is part of people's lives such as working out or cooking.
“Through music, we are giving fans a way to connect with each other or with other creators, brands, and personalities through simple, one-click sharing”, said Agustina Sacerdote, Global Head of Product at TIDAL. “Using Live offers music fans a simple route to finding new music from other fans in-app or wherever a link is shared. We’re excited to see how Live is used to power moments through sharing music and bringing people together”.
Live is available in-app on iOS and Android devices and TIDAL subscribers can select from over 100 million tracks available in-app. Tracks will play in normal AAC quality until high-resolution or lossless quality becomes available. Subscribers can only start and listen to sessions taking place in the country where their TIDAL account is registered.
Learn more about what’s coming up with TIDAL’s Live here
For information on TIDAL’s Early Access Program to try new features first sign up here.
Additional product information
- Live has limited functionality with third party devices.
- Subscribers can only start and listen to sessions taking place in the country where their TIDAL account is registered.
ABOUT TIDAL
TIDAL is a global music platform that helps fans and artists fully immerse themselves in their love of music. By helping artists with their business so they can focus on their craft and offering experiences that elevate how fans engage with music, artists and each other, TIDAL is the best platform for artists, fans, and all things music.
Available in 61 countries, the streaming service has more than over 100 million songs and over 650,000 high-quality videos in its catalog, along with original video series, thousands of expertly curated playlists, and artist discovery via TIDAL RISING. TIDAL is available in Free (US only), HiFi, and HiFi Plus tiers, with the HiFi Plus membership offering access to immersive audio features like Master Quality Authenticated (MQA) recordings, Dolby Atmos Music, and Sony’s 360 Reality Audio recordings, for a higher monthly fee that TIDAL redistributes back to artists.
TIDAL is part of Block, Inc. (NYSE: SQ), a global technology company with a focus on financial services.
For more information, please visit www.tidal.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230404005659/en/
Contact information
Media Contact: press@tidal.com
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 15:00:00 CEST | Press Release
NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under 20 minutes, saving hundreds of hours of engineer time, shrinking MTTR by more than 95%. A global telecommunications firm found NetBrain's context-grounded agents outperformed a stand-alone frontier LLM on a persistent firewall
Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 14:00:00 CEST | Press Release
Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consistent approach to protecting our innovation and our customers,” said Justin Ferguson, SVP and general counsel at Adtran. “We take all claims seriously, but we will not hesitate to defend ourselves when assertions lack merit. Situations like this place unnecessary strain on technology providers and divert resources from advancing networks and services. By advancing our counterclaim
Meiji Seika Pharma Invests in GHIC’s Global Health Security Fund29.5.2026 13:00:00 CEST | Press Release
Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, Japan; President and Representative Director: Toshiaki Nagasato) today announced that it has committed to invest in the Global Health Security Fund (GHSF), which is sponsored by Global Health Investment Corporation (GHIC), a New York-based nonprofit organization. Through this investment, Meiji Seika Pharma will support the acceleration of innovations addressing critical global health challenges, including pandemic preparedness and antimicrobial resistance (AMR). GHIC is a mission‑driven nonprofit organization that deploys private investment strategies to generate both global health impact and financial returns. GHIC recently closed its second fund in GHSF. With more than a decade of experience investing in the field of infectious disease, GHIC has contributed to addressing major global health challenges. Its portfolio companies have successfully commercialized more than a dozen products, collectively reaching over 600 million people wo
IFF Enters Into Agreement to Sell Its Food Ingredients Business to CVC29.5.2026 12:50:00 CEST | Press Release
IFF (NYSE: IFF), a global leader in flavors, fragrances, food ingredients, and health and biosciences, today announced that it has entered into an agreement to sell its Food Ingredients business to funds advised by CVC Capital Partners, a leading global private markets manager, in a transaction that values the business at approximately $4.3 billion, representing an enterprise value-to-EBITDA multiple of approximately 10x. As part of the transaction, IFF has chosen to retain an approximately 10% minority equity interest in the business, or approximately $200 million, permitting continued collaboration and cooperation between IFF and Food Ingredients and allowing IFF and its shareholders to participate in future value creation under its new ownership. The transaction marks a significant step in IFF’s portfolio transformation and is expected to strengthen the company’s focus on its innovation-driven businesses: Taste, Scent, and Health & Biosciences. Following the transaction, IFF will be
BeOne Medicines Establishes Standard for Long-Term Disease Control in CLL with BRUKINSA 78-Month Data at ASCO 202629.5.2026 12:00:00 CEST | Press Release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, is advancing the treatment paradigm in chronic lymphocytic leukemia (CLL) at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting. With extensive long-term follow-up, the SEQUOIA study of BRUKINSA® (zanubrutinib) reinforces its role as the foundational BTK inhibitor, showing sustained disease control over years of therapy. These findings are further supported by real-world evidence across three large analyses encompassing more than 250,000 patients, underscoring consistent effectiveness and safety in clinical practice. Additionally, BEQALZI™ (sonrotoclax), which was recently approved by the U.S. Food and Drug Administration, and its development in combination with BRUKINSA (ZS) highlight the potential for next-generation, time-limited treatment approaches in CLL. Amit Agarwal, M.D., Ph.D., Chief Medical Officer, Hematology, BeOne Medicines, said: “CLL is a disease patients live with
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom